Unique ID issued by UMIN | UMIN000034710 |
---|---|
Receipt number | R000039565 |
Scientific Title | Preventive effect of post-ERCP pancreatitis by cooling the duodenal papilla with ice water |
Date of disclosure of the study information | 2018/12/01 |
Last modified on | 2019/12/05 17:03:12 |
Preventive effect of post-ERCP pancreatitis by cooling the duodenal papilla with ice water
Ice water challenge
Preventive effect of post-ERCP pancreatitis by cooling the duodenal papilla with ice water
Ice water challenge
Japan |
Gallbladder cancer / bile duct cancer / pancreatic cancer / bile duct stone / cholangitis / pancreatitis / pancreatic cyst / pancreatic duct stenosis / biliary dilatation etc.
Hepato-biliary-pancreatic medicine |
Others
NO
To investigate whether to reduce the incidence of post-ERCP pancreatitis by cooling the papilla with ice water after ERCP.
Safety,Efficacy
Incidence of post-ERCP pancreatitis
Patient background (age, sex, past history of pancreatitis, PS, ASA, drinking history, smoking history etc.).
Presence or absence of cholangitis before treatment.
PEP incidence rate due to differences in ERCP procedures (bile duct obesity, pancreatic ductal purpose, EST, EPBD, biopsy, IDUS, biliary stent, pancreatic duct stent, etc.).
PEP incidence rate with or without pancreatic ductal intubation/ ductography.
PEP incidence rate due to bile duct intubation time.
Increase frequency and degree of pancreatic enzyme and inflammatory reaction (WBC, CRP) after 2 hours of ERCP/ next day in the above items.
The degree of PEP in the above items.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Before ending with ERCP, ice water is injected endoscopically into the lower duodenum to cool the duodenal papilla. Injection method uses a jet water pump, inject 250 ml of cold water.
20 | years-old | <= |
Not applicable |
Male and Female
ERCP can be enforced, there is no history of nipple treatment was enforced.
The age at registration is over 20 years old.
After getting enough explanation about participation in research, with sufficient understanding, written consent was obtained from the research subject himself / herself by the free will of the person him / herself.
Patient with a history of ERCP
Patient in postoperative reconstructed intestinal tract (Except for billroth-I)
Patients with acute pancreatitis
Patients who require drinking restriction due to heart failure etc.
Patients who are judged inappropriate for the research director or the attending physician to conduct this study
100
1st name | Shunjiro |
Middle name | |
Last name | Azuma |
Kitano Hospital Tazuke Kofukai Medical Research Institute
Gastroenterology and hepatology
534-8480
2-4-20 Ohgimachi, Kita-ku, Osaka city, Osaka
06-6312-1221
s-azuma@kitano-hp.or.jp
1st name | Shunjiro |
Middle name | |
Last name | Azuma |
Kitano Hospital Tazuke Kofukai Medical Research Institute
Gastroenterology and hepatology
534-8480
2-4-20 Ohgimachi, Kita-ku, Osaka city, Osaka, Japan
06-6312-1221
s-azuma@kitano-hp.or.jp
Kitano Hospital Tazuke Kofukai Medical Research Institute
Self funding
Self funding
Kitano Hospital Tazuke Kofukai Medical Research Institute
2-4-20 Ohgimachi, Kita-ku, Osaka city, Osaka, Japan
06-6312-1221
rinshou@kitano-hp.or.jp
NO
2018 | Year | 12 | Month | 01 | Day |
Unpublished
Completed
2018 | Year | 12 | Month | 01 | Day |
2018 | Year | 11 | Month | 22 | Day |
2018 | Year | 12 | Month | 01 | Day |
2019 | Year | 07 | Month | 13 | Day |
2019 | Year | 07 | Month | 13 | Day |
2018 | Year | 10 | Month | 31 | Day |
2019 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039565